22 Nw, LP Merrimack Pharmaceuticals Inc Transaction History

22 Nw, LP

  • $88.5 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$3.68 - $12.51 $794,754 - $2.7 Million
-215,966 Reduced 17.54%
1,015,048 $11.6 Million
Q3 2022

Nov 14, 2022
SELL
$3.7 - $6.06 $40,263 - $65,944
-10,882 Reduced 0.88%
1,231,014 $4.62 Million
Q2 2019

Aug 14, 2019
BUY
$4.39 - $5.66 $656,888 - $846,922
149,633 Added 13.7%
1,241,896 $7.51 Million
Q1 2019

May 15, 2019
BUY
$3.19 - $5.73 $1.09 Million - $1.97 Million
342,961 Added 45.77%
1,092,263 $7.59 Million
Q4 2018

Feb 08, 2019
BUY
$2.95 - $4.15 $2.21 Million - $3.11 Million
749,302 New
749,302 $2.89 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track 22 Nw, LP Portfolio

Follow 22 Nw, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 22 Nw, LP, based on Form 13F filings with the SEC.

News

Stay updated on 22 Nw, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email